- April 3, 2026
Loading
NeoGenomics selling 3 million shares, sets price to generate $7.8 million
NeoGenomics Inc., a Fort Myers-based cancer-focused genetic testing service, has priced a public offering of 3.15 million shares of common stock at $3 per share. The company plans to sell 2.85 million shares and The Mary S. Dent Gifting Trust will sell another 300,000 NeoGenomics shares.